These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7363931)

  • 1. Relationship between blood and cerebrospinal levels of the antidepressant agent viloxazine.
    Elwan O; Adam HK
    Eur J Clin Pharmacol; 1980; 17(3):179-82. PubMed ID: 7363931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood level studies with viloxazine hydrochloride in man.
    Bayliss PF; Case DE
    Br J Clin Pharmacol; 1975 Jun; 2(3):209-14. PubMed ID: 1234502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive gas chromatographic assay for the determination of serum viloxazine concentration using a nitrogen-phosphorus-selective detector.
    Fazio A; Crisafulli P; Primerano G; D'Agostino AA; Oteri G; Pisani F
    Ther Drug Monit; 1984; 6(4):484-8. PubMed ID: 6515713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetic study of conventional and sustained-release viloxazine in normal volunteers.
    Kergueris MF; Bourin M; Ribeyrol M; Beneroso N; Normand YL; Larousse C
    Neuropsychobiology; 1989; 20(3):136-40. PubMed ID: 2761683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of viloxazine hydrochloride in man.
    Vandel B; Vandel S; Jounet JM; Blum D
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):65-8. PubMed ID: 7067726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viloxazine plasma concentrations and clinical response.
    Norman TR; Burrows GD; Davies BM; Maguire KP; Wurm JM
    J Affect Disord; 1980 Sep; 2(3):157-64. PubMed ID: 6210721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of viloxazine in plasma by GLC.
    Norman TR; Burrows GD; Davies BM; Wurm JM
    Br J Clin Pharmacol; 1979 Aug; 8(2):169-71. PubMed ID: 486292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step extraction procedure for gas chromatographic determination of viloxazine as its acetyl derivative in human plasma.
    Groppi A; Papa P
    J Chromatogr; 1985 Jan; 337(1):142-5. PubMed ID: 3980644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacokinetics of viloxazine chlorhydrate. Practical implications].
    Bouquet S; Vandel B; Guibert S; Lavoisy J
    Encephale; 1989; 15(5):443-7. PubMed ID: 2686964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment.
    Pisani F; Fazio A; Spina E; Artesi C; Pisani B; Russo M; Trio R; Perucca E
    Psychopharmacology (Berl); 1986; 90(3):295-8. PubMed ID: 3097715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of administration route on pharmacokinetics of viloxazine in the rabbit.
    Thomare P; Bourin M; Kergueris MF; Ortega A; Larousse C
    Methods Find Exp Clin Pharmacol; 1992 Mar; 14(2):125-9. PubMed ID: 1598024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine-viloxazine interaction in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Perucca E; Russo M; Trio R; Pisani B; Di Perri R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1142-5. PubMed ID: 3783175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viloxazine in depressed women: clinical response and cardiovascular effects.
    Corona GL; Frattini P; Cucchi ML; Santagostino G; Schinelli S; Zerbi F; Cairoli S; Tosca P; Savoldi F
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):322-7. PubMed ID: 3623737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term tolerance of viloxazine].
    Brion S; Chevalier JF
    Encephale; 1982; 8(4):511-21. PubMed ID: 7151740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].
    Brion S; Chevalier JF; Guerin R; Ginestet D
    Encephale; 1976; 2(3):257-71. PubMed ID: 991806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of viloxazine on serum carbamazepine levels in epileptic patients.
    Pisani F; Narbone MC; Fazio A; Crisafulli P; Primerano G; D'Agostino AA; Oteri G; Di Perri R
    Epilepsia; 1984 Aug; 25(4):482-5. PubMed ID: 6745218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined treatment with nialamide and viloxazine in depressed patients (author's transl)].
    Kabes J
    Cesk Psychiatr; 1979 Jun; 75(3):166-74. PubMed ID: 527077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.